Pulmatrix (PULM)

This biopharma’s stock was added to the Russell Microcap Index last month, and its shares are gathering momentum. Pulmatrix (PULM) From The Konlin Letter More than 30 million Americans and 30 million Europeans have a rare disease. Pulmatrix (PULM) is a clinical stage biopharmaceutical company innovative,...
Read More

Pulmatrix, Inc. (PULM)

Stonegate Capital Partners just initiated coverage on this biotech company. Pulmatrix, Inc. (PULM) From The Konlin Letter Pulmatrix, Inc. (PULM) is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease. PULM’s proprietary product pipeline is focused on advancing treatments for diseases,...
Read More

The KonLin Letter

The KonLin Letter is a unique service that recommends five low-priced stock selections each month including a featured stock of the month, and reviews 30 to 35 different small caps while monitoring a broad range of technical indicators for the best possible Market Advice...
Read More

Top Pick: TONIX Pharmaceutical Holdings, Inc. (TNXP)

Today’s new Top Pick for 2013 comes from The KonLin Letter Editor Konrad Kuhn, whose research into this Pink Sheets-listed pharmaceutical suggests it has the potential to more than quintuple in price. “Fibromyalgia syndrome (FM) is a common and complex central nervous system condition by...
Read More

Top Picks 2012 Updates Part 1

Today’s Daily Alert brings the first of your subscriber-only updates on the Top Picks for 2012, including the advisors’ current advice on the stocks wherever possible. There are a lot of updates, so I’ve broken them down into more digestible segments that will spread...
Read More

Top Trends from 2011

Every January, we publish two special issues of the Dick Davis Digests, featuring our contributing experts' favorite stock picks for the coming year. In addition to giving subscribers direct access to our contributors' best ideas, the Top Picks issues also provide an at-a-glance at...
Read More

Top Picks for 2011 Winners

As I mentioned here last week, every July the Dick Davis Digests publish updates on our contributors' Top Picks for the year (which were first recommended in January). As promised, today I'm highlighting some of those picks that have performed best over the six...
Read More

An Investment in Efficiency

Last week, I asked readers what they thought of airlines’ complex pricing schemes. (If you missed the issue, you can still read it  here on the website.) Several of you responded with interesting comments, including the ones below. For the most part I have...
Read More